Accenture Plc (NYSE: ACN) disclosed on Tuesday that it has finalized an agreement to purchase Faculty, a UK-headquartered artificial intelligence firm. This acquisition is a strategic effort to enhance Accenture’s provision of sophisticated AI services for enterprise customers. Driven by expanding needs from corporations and governmental agencies for AI solutions that combine significant capability with deployment safety, the transaction represents a key milestone in Accenture’s AI growth trajectory.
Faculty, established in 2014, is renowned for applying AI in environments characterized by mission-critical and high-risk parameters. The company’s expertise extends across a comprehensive range of AI functions, including strategic planning, development of safety frameworks, and system implementation. A central aspect of Faculty’s approach emphasizes mitigating algorithmic bias, maintaining stringent data privacy protections, and guaranteeing that AI models are both transparent and explainable.
With this acquisition, Accenture integrates more than 400 AI professionals, significantly expanding its global skill base. The Faculty team brings advanced competencies in decision intelligence, enhancing Accenture’s capability to execute secure, large-scale AI-driven projects for its diverse client portfolio. Financial terms of the deal remain confidential.
Marc Warner, Faculty’s chief executive officer, will assume the role of chief technology officer at Accenture upon completion of the transaction. He will additionally join Accenture’s Global Management Committee. Warner’s background includes academic research and participation in shaping AI policy initiatives within the United Kingdom, lending valuable experience to his new position.
Faculty’s Frontier decision intelligence platform, a technology that unites data, artificial intelligence models, and operational workflows to facilitate expedited and improved decision-making, will be incorporated into Accenture’s suite of technology offerings. This platform is already deployed in collaborations with major clients such as Novartis AG (NYSE: NVS), where it supports enhanced planning and execution of clinical trials.
Market analysts observe strong momentum in Accenture’s AI expansion efforts, despite many client projects remaining in preliminary stages. Investments related to artificial intelligence and robotics are also accessible to investors through vehicles like the Global X Robotics & Artificial Intelligence ETF (NASDAQ: BOTZ) and iShares U.S. Technology ETF (NYSE: IYW).
As of November 30, 2025, Accenture held a cash balance totaling $9.6 billion, underscoring robust financial resources to support ongoing growth initiatives including strategic acquisitions.
Looking ahead, Accenture intends to scale Faculty’s Fellowship Program on a global basis to cultivate a broader pipeline of advanced AI talent. The deal remains subject to customary regulatory approvals before its closure can be finalized.
Following the announcement, Accenture’s stock traded slightly lower, decreasing 0.22% to $263.39 in premarket activity on Tuesday, as reported by Benzinga Pro.